Taysha gene therapies to release third quarter 2023 financial results and host conference call and webcast on november 14

Dallas, nov. 07, 2023 (globe newswire) -- taysha gene therapies, inc. (nasdaq: tsha), a clinical-stage gene therapy company focused on developing and commercializing aav-based gene therapies for the treatment of monogenic diseases of the central nervous system (cns), today announced that it will report its financial results for the third quarter ended september 30, 2023, and host a corporate update conference call and webcast on tuesday, november 14, 2023, at 4:30 pm eastern time.
TSHA Ratings Summary
TSHA Quant Ranking